Author: nicholasdore

Renewal will use technology developed at the Weizmann Institute of Science to drive advancements in infertility, genetic diseases therapies, lab-grown organs, and blood system rejuvenation REHOVOT, ISRAEL – WEBWIRE – Wednesday, August 3, 2022 Renewal Bio, a newly formed biotechnology company focused on infertility and longevity, today announced it has acquired an exclusive license from Yeda Research and Development Co Ltd, the commercial arm of the Weizmann Institute of Science, to a newly developed synthetic embryo technology. The technology was spearheaded by Prof. Jacob Hanna, Ph.D., M.D., as recently published in Cell, and builds on his research published ... Read more